comparemela.com

Latest Breaking News On - Jim breitmeyer - Page 1 : comparemela.com

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q1 2024 Earnings Call Transcript

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Carl-byrnes
Salim-yazji
Richard-vincent
Kemp-dolliver
Robert-burns
Jim-breitmeyer
James-breitmeyer
Hartaj-singh
Oncternal-therapeutics-inc
Nasdaq
Oppenheimer-company
International-students

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q1 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the Oncternal Therapeutics First Quarter 2023 Financial Results Call. As a reminder, this conference will be recorded.

Hartaj-singh
James-breitmeyer
Rosemary-li
Carl-byrnes
Kemp-dolliver
Salim-yazji
Jim-breitmeyer
Richard-vincent
Li-watsek
Nasdaq
Boeing
Oncternal-therapeutics-inc

Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q1 2022 Results - Earnings Call Transcript

Oncternal Therapeutics, Inc (NASDAQ:NASDAQ:ONCT) Q1 2022 Earnings Conference Call May 5, 2022, 5:00 PM ET Company Participants James Breitmeyer – President & Chief Executive Officer.

Brookline
Massachusetts
United-states
Dana-farber-cancer-institute
China
California
San-diego
Chicago
Illinois
Ukraine
American
Kumar-raja

vimarsana © 2020. All Rights Reserved.